Aberdeen Group’s Chemours CC Stock Holding History

Aberdeen Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,606	Closed	-$255K	–	923
2019 Q2	$255K	Buy	10,606 +1,194	+13%	+$35.2K	﹤0.01%	920
2019 Q1	$350K	Hold	9,412	–	–	﹤0.01%	888
2018 Q4	$262K	Sell	9,412 -99	-1%	-$3.13K	﹤0.01%	866
2018 Q3	$375K	Sell	9,511 -817	-8%	-$35.7K	﹤0.01%	888
2018 Q2	$458K	Buy	+10,328	New	+$514K	﹤0.01%	858

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aberdeen Group's CC Position: Q3 2019 in Review

Aberdeen Group sold out of Chemours (CC) in Q3 2019, closing a stake of 10,606 shares — an estimated $255K sold.

Aberdeen Group first reported a position in CC in Q2 2018 and held it in 5 quarters. The position peaked at $458K in Q2 2018. 419 funds tracked by Wall St. Rank hold CC as of Q3 2019.

Aberdeen Group reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
Aberdeen Group sold 10,606 Chemours shares in Q3 2019, an estimated $255K.
Aberdeen Group first reported a position in Chemours in Q2 2018 and held it in 5 quarters.
Aberdeen Group's Chemours position peaked at $458K in Q2 2018.
419 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.